Dave Edwards, Chief Revenue Officer, MasterControl03.01.21
This year holds the promise of everyone receiving a vaccine for COVID-19. Contract pharmaceutical manufacturers are at the heart of these efforts, and skyrocketing demand requires the industry to move even faster than before. There couldn’t be a more important time to evaluate manufacturing processes and eliminate anything causing unnecessary delays, and there are five key reasons why the first thing to go should be paper on the shop floor.
1. During a labor shortage, pushing paper costs time nobody can afford
An urgent need for COVID-19 vaccines and treatments has created a considerable labor shortage within the contract manufacturing industry.
The Wall Street Journal recently reported an estimated six billion doses of COVID-19 vaccines will be produced in 2021. The major pharmaceutical companies with a vaccine candidate are relying on contract manufacturers to help with production. The strain on resources is apparent as the world’s 10 largest companies that won CO
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
